Want to see COLL full AI Analyst Report?
Collegium Pharmaceutical (COLL) Q4 2019 Earnings Report
513 Followers
COLL Q4 2019 EPS Results
- Actual EPS
- $0.16
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$0.10
COLL Q4 2019 Revenue Results
- Actual Revenue
- $74.20M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +1.06%
Earnings Announcement Details
- Quarter
- Q4 2019
- Date
- 02/27/2020
- Time
- After Close
- Conference Call
- Thursday, February 27, 2020
COLL Upcoming Earnings
Collegium Pharmaceutical's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q4 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
COLL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | ―- | 2.04 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 1.860.69 | 2.25 | -69.33% (-1.56) | |
| Aug 06, 2026 | 2026 (Q2) | 1.721.92 | 1.68 | 14.29% (+0.24) | |
| May 07, 2026 | 2026 (Q1) | 1.521.76 | 1.49 | 18.12% (+0.27) | |
| Feb 26, 2026 | 2025 (Q4) | 2.142.04 | 1.77 | 15.25% (+0.27) | |
| Nov 06, 2025 | 2025 (Q3) | 1.862.25 | 1.61 | 39.75% (+0.64) | |
| Aug 07, 2025 | 2025 (Q2) | 1.621.68 | 1.62 | 3.70% (+0.06) | |
| May 08, 2025 | 2025 (Q1) | 1.431.49 | 1.45 | 2.76% (+0.04) | |
| Feb 27, 2025 | 2024 (Q4) | 1.541.77 | 1.58 | 12.03% (+0.19) | |
| Nov 07, 2024 | 2024 (Q3) | 1.591.61 | 1.34 | 20.15% (+0.27) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
